14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Monday, 8th Apr 2024 USRM stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0048

Historical U.S. Stem Cell, Inc. prices

Date Open High Low Close Volume
Apr 08, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Apr 05, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Apr 04, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Apr 03, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Apr 02, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Apr 01, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 28, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 27, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 26, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 25, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 22, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 21, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 20, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 19, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 18, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 15, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 14, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 13, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 12, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 11, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 08, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 07, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 06, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 05, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 04, 2024 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About U.S. Stem Cell, Inc.

U.S. Stem Cell. U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's... USRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT